Sex Differences in Age of Diagnosis, HLA Genotype, and Autoantibody Profile in Children With Type 1 Diabetes.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
01 11 2023
Historique:
received: 22 01 2023
accepted: 11 08 2023
medline: 30 10 2023
pubmed: 12 9 2023
entrez: 12 9 2023
Statut: ppublish

Résumé

To examine sex differences in children with newly diagnosed type 1 diabetes (T1D) with respect to age at diagnosis, presence of autoantibodies (GAD antibody [GADA], insulinoma-associated protein 2 [IA-2A], insulin autoantibody [IAA], and zinc transporter 8 autoantibody), and HLA risk. A population-based nationwide sample of 3,645 Swedish children at T1D diagnosis was used. Girls were younger at T1D diagnosis (9.53 vs. 10.23 years; P < 0.001), more likely to be autoantibody-positive (94.7% vs. 92.0%; P = 0.002), more often positive for multiple autoantibodies (P < 0.001), more likely to be positive for GADA (64.9% vs. 49.0%; P < 0.001), and less likely to be positive for IAA (32.3% vs. 33.8%; P = 0.016). Small sex differences in HLA risk were found in children <9 years of age. The disease mechanisms leading to T1D may influence the immune system differently in girls and boys.

Identifiants

pubmed: 37699205
pii: 153596
doi: 10.2337/dc23-0124
doi:

Substances chimiques

Autoantibodies 0
HLA-DQ Antigens 0
Insulin Antibodies 0
Glutamate Decarboxylase EC 4.1.1.15

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1993-1996

Informations de copyright

© 2023 by the American Diabetes Association.

Auteurs

Jasaman Tojjar (J)

Department of Clinical Sciences, Lund University, Lund, Sweden.

Matti Cervin (M)

Department of Clinical Sciences, Lund University, Lund, Sweden.

Emma Hedlund (E)

Department of Clinical Sciences, Lund University, Lund, Sweden.
Department of Paediatrics, Kristianstad Central Hospital, Kristianstad, Sweden.

Qefsere Brahimi (Q)

Department of Clinical Sciences, Malmö, Clinical Research Center, Lund University, Malmö, Sweden.

Gun Forsander (G)

The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.

Helena Elding Larsson (H)

Department of Clinical Sciences, Malmö, Clinical Research Center, Lund University, Malmö, Sweden.
Skåne University Hospital, Malmö, Sweden.

Johnny Ludvigsson (J)

Crown Princess Victoria Childreńs Hospital, Linköping University Hospital, Linköping, Sweden.
Division of Pediatrics, Department of Biomedical and Clinical Sciences (BKV), Medical Faculty, Linköping University, Linköping, Sweden.

Ulf Samuelsson (U)

Crown Princess Victoria Childreńs Hospital, Linköping University Hospital, Linköping, Sweden.
Division of Pediatrics, Department of Biomedical and Clinical Sciences (BKV), Medical Faculty, Linköping University, Linköping, Sweden.

Claude Marcus (C)

Division of Pediatrics, Department of Clinical Science Intervention and Technology, Karolinska Institute, Stockholm, Sweden.

Martina Persson (M)

Department of Medicine, Clinical Epidemiology, Karolinska Institute, Stockholm, Sweden.
Department of Clinical Science and Education, Karolinska Institute, Södersjukhuset, Stockholm, Sweden.

Annelie Carlsson (A)

Department of Clinical Sciences, Lund University, Lund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH